The incidence of liver disease progression among subjects with histologically advanced but compensated chronic hepatitis C is incomplete. The Hepatitis C Antiviral Long-term Treatment against Cirrhosis Trial was a randomized study of 3.5 years of maintenance peginterferon treatment on liver disease
Prognosis of chronic hepatitis c: Results of a large, prospective cohort study
✍ Scribed by Claus Niederau; Stefan Lange; Tobias Heintges; Andreas Erhardt; Marlies Buschkamp; Dietmar Hürter; Marek Nawrocki; Lothar Kruska; Frank Hensel; Wolfgang Petry; Dieter Häussinger
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 110 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
We examined the feasibility of hepatitis C treatment in patients on opioid maintenance. One hundred patients with chronic hepatitis C, 50 on methadone maintenance, and 50 with no intravenous drug use or opioid maintenance for at least 5 years were prospectively matched for sex, age, hepatitis C viru
Because interferon therapy exhibits low efficacy for cirrhotic patients infected with hepatitis C virus, this prospective study was conducted to determine effective interferon regimens tailored to treatment response by monitoring HCV RNA status. A total of 157 cirrhotic patients were enrolled to rec
## Abstract Although persistent transmission of hepatitis C virus (HCV) from infected mothers to their infants is reported in 4–8%, transient HCV perinatal infection also occurs. This prospective cohort study determined perinatal HCV infection‐ and early and late clearance‐rates in 1,863 mother‐inf
## Abstract The natural course of hepatitis C virus (HCV) infection has not been fully elucidated. To investigate whether HCV is spontaneously eliminated in chronic carriers, a long‐term population‐based cohort study was conducted on 435 chronic HCV carriers. Individual characteristics, serum HCV R